sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
TXG
Updated 10/6/2026, 10:27 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| TXG 10x Genomics, Inc. | Sale | $464,668 | SULIMAN SHEHNAAZ Director | 5,723 sh | at $81.19 | Filed Sep 24, 4:30 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $2,030,562 | Saxonov Serge Chief Executive Officer, Director | 25,000 sh | at $81.22 | Filed Sep 24, 4:29 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $2,995,470 | Taich Adam Chief Financial Officer | 46,388 sh | at $64.57 | Filed Sep 11, 4:47 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $1,235,072 | STUELPNAGEL JOHN R Director | 20,000 sh | at $61.75 | Filed Sep 8, 7:00 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $667,901 | Saxonov Serge Chief Executive Officer, Director | 10,486 sh | at $63.69 | Filed Aug 28, 7:22 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $1,168,775 | Saxonov Serge Chief Executive Officer, Director | 18,545 sh | at $63.02 | Filed Aug 26, 4:46 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $1,081,853 | Taich Adam Chief Financial Officer | 17,166 sh | at $63.02 | Filed Aug 26, 4:44 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $870,860 | Hindson Benjamin J. See Remarks, Director | 13,818 sh | at $63.02 | Filed Aug 26, 4:43 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $140,478 | SULIMAN SHEHNAAZ Director | 2,207 sh | at $63.65 | Filed Aug 26, 4:42 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $432,279 | Teichmann Sarah A. Director | 7,551 sh | at $57.25 | Filed Aug 17, 4:08 PM ET | Filing | |
| TXG 10x Genomics, Inc. | Sale | $1,155,055 | STUELPNAGEL JOHN R Director | 20,000 sh | at $57.75 | Filed Aug 13, 4:11 PM ET | Filing |